Initial commercial deployment of a CLIA-certified functional drug test for refractory cancer patients. Grant

Initial commercial deployment of a CLIA-certified functional drug test for refractory cancer patients. .

date/time interval

  • June 9, 2025 - June 8, 2026

awarded by

sponsor award ID

  • N/A

contributor